Multifaceted Approaches in Epithelial Cell Adhesion Molecule-Mediated Circulating Tumor Cell Isolation

Area of Science:

• Oncology
• Cell Biology
• Biomarker Discovery

Background:

• Circulating tumor cells (CTCs) are key indicators of cancer metastasis and essential for monitoring disease progression.
• Current methods often rely on the epithelial cell adhesion molecule (EpCAM) for isolating CTCs.
• However, tumor cell heterogeneity and the epithelial-to-mesenchymal transition (EMT) phenomenon can reduce EpCAM expression, hindering capture efficacy.

Purpose of the Study:

• To critically review the role of EpCAM in CTC capture.
• To explore the impact of EMT on EpCAM expression and CTC isolation.
• To discuss alternative biomarkers and strategies for enhancing CTC detection in liquid biopsies.

Main Methods:

• Literature review of existing studies on CTC capture techniques.
• Analysis of the effects of epithelial-to-mesenchymal transition on EpCAM expression.
• Evaluation of alternative biomarkers and novel isolation strategies.

Main Results:

• EpCAM expression is significantly altered during epithelial-to-mesenchymal transition, limiting its utility as a universal CTC marker.
• Heterogeneity among CTCs further complicates EpCAM-dependent isolation.
• Alternative markers and multi-marker approaches show promise for broader CTC detection.

Conclusions:

• EpCAM-based CTC capture is insufficient due to EMT and cell heterogeneity.
• Developing novel, EpCAM-independent strategies is crucial for comprehensive liquid biopsy.
• Improved CTC isolation will enhance cancer diagnosis, prognosis, and treatment monitoring.